Nextgen Healthcare Inc 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nextgen Healthcare Inc 's ROA in the second quarter of 2024?
Nextgen Healthcare Inc recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -0.72%.

However, within the Technology sector 298 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2024 from 2752 to 2901.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2023) II. Quarter	(Jun 30 2023) I. Quarter	(Mar 31 2023) IV. Quarter	(Dec 31 2022) III. Quarter	(Sep 30 2022) II. Quarter
Y / Y Total Assets Change	36.9 %	44.06 %	30.56 %	45.78 %	0.17 %
Y / Y Net Income Change	-62.89 %	436.24 %	-	50.49 %	-
Net Income (TTM) in million	-6	2	-3	23	20
Return On Assets (TTM)	-0.72 %	0.29 %	-0.36 %	3.31 %	3.25 %
NXGN's Total Ranking	# 2901	# 2752	# 3004	# 2071	# 1864
Total Assets (TTM) in million	852	863	891	865	622
Seq. Total Assets Change	-1.22 %	-3.16 %	3.04 %	38.91 %	3.94 %
Seq. Net Income Change	-17.88 %	-	-	-42.63 %	1086.67 %

NXGN's 5 Years Annual ROA >> Back to NXGN Management Effectiveness >> Compare NXGN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 49
Sector	# 299
Overall	# 2863

Return On Assets Statistics
High	Average	Low
17.85 %	2.27 %	-17.91 %
		(Dec 31 2013)

Financial Statements
Nextgen Healthcare Inc 's Assets	$ 852 million	NXGN's Balance sheet
Nextgen Healthcare Inc 's Income	$ 5 million	Quarterly NXGN's Income Statement
NXGN's Income by Division		See NXGN's Income by Division

Annual Return On Assets	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022	(Mar 31 2021) FY 2021	(Mar 31 2020) FY 2020	(Mar 31 2019) FY 2019
Y / Y Total Assets Change	44.59 %	-1.74 %	-8.83 %	29.07 %	3.32 %
Total Assets in million	891	616	627	688	533
Y / Y Net Income Change	-	-83 %	26.9 %	-69.39 %	912.15 %
Net Income in million	-3	2	10	7	24
Annual Return On Assets	-0.3 %	0.26 %	1.52 %	1.09 %	4.6 %

NXGN's 5 Years Annual ROA >> Back to NXGN Management Effectiveness >> Compare NXGN ROA to its Competitors

More Return On Assets Ratios
NXGN's' Return on Assets at Yahoo Finance
Cloud Computing & Data Analytics Industry Return On Assets Trends and Statistics
Technology Sector Roa Statistics
Roa Trends for overall market
NXGN's Roa Ratio versus Cloud Computing & Data Analytics Industry, Technology Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NXGN's Competitors
Subscribers only: Roa for Nextgen Healthcare Inc 's Suppliers
Subscribers only: Return On Assets for NXGN's Customers

You may also want to know
NXGN's Roi	NXGN's Inventory Turnover Ratio	NXGN's Growth Rates	NXGN's Dividend Comparisons
	NXGN's Profitability Ratios	NXGN's Asset Turnover Ratio	NXGN's Dividend Growth
NXGN's Roe	NXGN's Valuation Ratios	NXGN's Financial Strength Ratios	NXGN's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2023, within Technology Sector

ROA

Date modified: 2026-09-26T06:56:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.